Measurement of granulocyte maturation may improve the early diagnosis of the septic state

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 12, 2011, Pages 2089-2095

  Bernstein, Larry H ^a,c   Rucinski, James ^b  

^a NORWALK HOSPITAL   (United States)

^b NEW YORK METHODIST HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Bacteremia; Flow cytometry; Hemogram; Immature granulocyte; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

ARTICLE; CELL MATURATION; EARLY DIAGNOSIS; FEMALE; GRANULOCYTE; HUMAN; IMMATURE GRANULOCYTE; LEUKOCYTOSIS; LEUKOPENIA; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; MALE; MICROCYTIC ANEMIA; NORMOCHROMIC NORMOCYTIC ANEMIA; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 84856512767     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.688     Document Type: Article

References (34)

1. Slade E, Tamber PS, Vincent. JL. The surviving sepsis campaign: Raising awareness to reduce mortality. Crit Care 2003;7:1-2. (Pubitemid 36204256)
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus. Conference. Crit Care Med 1992;20: 864-74.
3. Pilz G, Kääb S, Werdan K, Kreuzer E. Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery. Infection 1994;22:8-17. (Pubitemid 24051837)
4. Lappen JR, Keene M, Lore M, Grobman WA, Gossett DR. Existing models fail to predict sepsis in an obstetric population with intrauterine infection. Am J Obstet Gynecol 2010;203: 573.e1-5.
5. Pancer G, Engelman E, Hoque F, Alam M, Rucinski J, Bernstein LH. C-reactive protein for the enhanced evaluation of the systemic inflammatory response syndrome (SIRS). The Open Clin Chem J 2010;3:90-8.
6. Devakonda A, George L, Raoof S, Esan A, Saleh A, Bernstein, LH. Transthyretin as a marker to predict outcome in critically ill patients. Clin Biochem 2008;41:1126-30.
7. Bernstein LH, Devakonda A, Engelman E, Pancer G, Ferrara J, Rucinski J, et al. The role of procalcitonin in the diagnosis of sepsis and patient assignment to medical intensive care. J Clin Ligand Assay 2007;30:98-104.
8. Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: A critical review. Pediatr Infect Dis J 1995;14:1119-20. (Pubitemid 26008476)
9. Ahmed Z, Ghafoor T, Waqar T, Ali S, Aziz S, Mahmud S. Diagnostic value of C-reactive protein and haematological parameters in neonatal sepsis. J Coll Physicians Surg Pak 2005;15:152-6. (Pubitemid 40575961)
10. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997;16:735-47. (Pubitemid 27364784)
11. Benitz WE, Han MY, Madan A, Ramachandra P. Serial Measurements of serum C-reactive protein in the diagnosis of neonatal infection. Pediatrics 1998;102:1-10.
12. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: Systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7. (Pubitemid 46274517)
13. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006;34:1996-2003. (Pubitemid 43982479)
14. Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2010;38:2229-41.
15. Tang H, Huang T, Jing J, Shen H, Cui W. Effect of procalcitonin-guided treatment in patients with infections: A systematic review and meta-analysis. Infection. 2009;37:497-507.
16. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010;375: 463-74.
17. Ardron MJ, Westengard JC, Dutcher TF. Band neutrophil counts are unnecessary for the diagnosis of infection in patients with normal total leukocyte counts. Am J Clin Pathol 1994;202:646-9. (Pubitemid 24337559)
18. Cornbleet PJ. Clinical utility of the band count. Clin Lab Med 2002;22:101-36. (Pubitemid 34242268)
19. Walling HW, Marian FA. Predictive value of leukocytosis and neutrophilia for bloodstream infection. Infect Dis Clin Pract 2004;12:2-6. (Pubitemid 38133154)
20. Chung CH, Choi JW, Lee J. Delta neutrophil index in automated immature granulocyte counts for assessing severity of patients with sepsis. Ann Clin Lab Sci 2008;38:241-6.
21. Cornbleet PJ. Clinical utility of the band count. Clin Lab Med 2002;22:101-36. (Pubitemid 34242268)
22. Ansari-Lar MA, Kickler TS, Borowitz MJ. Immature granulocyte measurement using the Sysmex XE-2100: Relationship to infection and sepsis. Am J Clin Pathol 2003;120:795-9. (Pubitemid 37339689)
23. Field D, Taube E, Heumann S. Performance evaluation of the immature granulocyte parameter on the Sysmex XE-2100 automated hematology analyzer. Lab Hematol 2006;12:11-4.
24. Fernandes B, Hamaguchi Y. Automated enumeration of immature granulocytes. Am J Clin Pathol 2007;128:454-63. (Pubitemid 47479979)
25. Nigro KG, O'Riordan MA, Molloy EJ, Walsh MC, Sanhaus LM. Performance of an automated immature granulocyte count as a predictor of neonatal sepsis. Am J Clin Pathol 2005;123: 618-24. (Pubitemid 40418558)
26. The cost Burden of Disease: US and Michigan. Most common causes for hospitalization in 2007. The Center for Healthcare Research & Transforation (CHRT). Issue Brief January 2010. http: / / www.chrt.orj / assets / price-of-care /CHRT-Issue-Brief-January-2010.pdf.
27. Russo CA, Andrews RM. The National Hospital Bill: The most expensive conditions, by payer, 2004. Statistical brief 13. Healthcare cost and utilization project. Agency for Healthcare Research and Quality 2006.
28. Barcelona Declaration. Surviving Sepsis Campaign. European Society of Intensive Care Medicine, the International Sepsis Forum, and the Society of Critical Care Medicine. Concluded December 31, 2008. http://ssc.sccm.orj/ background/barcelona-declaration.
29. Van Gestel A, Bakker J, Veraart CP, Van Hout BA. The costs of severe sepsis; The Netherlands, 2000. Health Economics and Reimbursement Services.
30. Groundbreaking Severe Sepsis Prevention Program Saves 991 Lives, Reduces Costs by $36.5 Million. CHW.
31. Reducing sepsis mortality and costs at CAMC. HCFMA. January 06, 2010.
32. Roehrl MH, Lantz D, Sylvester C, Wang JY. Age-dependent reference ranges for automated assignment of immature granulocytes and clinical significance in an outpatient setting. Arch Pathol Lab Med 2011;135:471-7.
33. Bakker J, de Munck P, Rommes H, Van Bussel H. Costs of severe sepsis in a multidisciplinary intensive care unit. Crit Care Med 1998;26:A131. (Pubitemid 128778622)
34. Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky MB, et al. A German national prevalence study on the cost of intensive care: An evaluation from 51 intensive care units. Crit Care 2007;11:R69.